Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00210-012-0824-1.pdf
Reference39 articles.
1. Aizawa N, Homma Y, Igawa Y (2012) Effects of mirabegron, a novel β3-adrenoceptor agonist, on the primary bladder afferent activity and bladder microcontractions in rats in comparison with those of oxybutynin. Eur Urol 62:1166–1173
2. Arch JRS (2008) Perspectives from β3-adrenoceptor agonists on pharmacology, physiology and obesity drug discovery. Naunyn-Schmiedeberg’s Arch Pharmacol 378:225–240
3. Biers SM, Reynard JM, Brading AF (2006) The effects of a new selective β3-adrenoceptor agonist (GW427353) on spontaneous activity and detrusor relaxation in human bladder. BJU Int 98:1310–1314
4. Brown L, Deighton NM, Bals S, Söhlmann W, Zerkowski H-R, Michel MC, Brodde O-E (1992) Spare receptors for β-adrenoceptor-mediated positive inotropic effects of catecholamines in the human heart. J Cardiovasc Pharmacol 19:222–232
5. Cernecka H, Ochodnicky P, Lamers WH, Michel MC (2012) Specificity evaluation of antibodies against human β3-adrenoceptors. Naunyn-Schmiedeberg’s Arch Pharmacol 385:875–882
Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The impact of pharmacotherapy on sexual function in female patients being treated for idiopathic overactive bladder: a systematic review;BMC Women's Health;2024-05-16
2. Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in female patients with refractory overactive bladder: a prospective study;Frontiers in Neuroscience;2024-04-10
3. Inside the Biology of the β3-Adrenoceptor;Biomolecules;2024-01-29
4. Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays;Handbook of Experimental Pharmacology;2024
5. Mirabegron, a Selective β3-Adrenergic Receptor Agonist, as a Potential Anti-Obesity Drug;Journal of Clinical Medicine;2023-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3